Dr. Anil Thakwani, M.D.

MBBS, MD, F.C.C.S(California), NUTAS(China) Director and Senior consultant clinical oncologist
doctor-foto
Dr. Anil Thakwani, M.D.
MBBS, MD, F.C.C.S(California), NUTAS(China) Director and Senior consultant clinical oncologist
Timings:
  •  Monday 5PM - 8PM 
  • Tuesday 5PM - 8PM
  •  Wednesday - Closed 
  • Thursday 5PM - 8PM 
  • Friday 5PM - 8PM 
  • Saturday 5PM - 8PM 
  • Sunday 12PM - 2PM
Available at Vejovis Clinic
Shop no. 18, First Floor,
Shopping Arcade, Lotus Panache,Sector 110, Noida, Uttar Pradesh 201304, India

Dr. Anil Takwani, A leading, distinguished clinical oncologist, in Delhi NCR,Having 21 years in superior advanced radiation skill in oncology patient management ,having expertise in Breasts &cervix cancers, Head & Neck cancers ,Bone and soft tissues malignancies,Brain tumours,Lung cancer ,colon cancer and paediatric oncology Having experience in using the latest and advanced technology in cancer detection and treatment .i,e 3DCRT.IMRT,IGRT,SBRT,SRT,GATI NG,Radiation Therapy,GAMMA knife,Chemo therapy ,Immunotherapy,and Targeted Therapies.

WORK EXPERIENCE

  • Senior consultant Oncologist     2020-Recent
    Fortis Hospital, Noida.
  • Director and Head Oncology     2018-Recent
    Sharda hospital, Gr.Noida.
  • Senior consultant Oncologist     2018-Recent
    Jaypee Hospital, Noida.
  • Senior consultant Clinical Oncologist     2011-2020
    Batra Hospital & research center,Delhi.
  • Senior consultant Oncologist     2017-2019
    Apollo Spectra center, New Delhi
  • Astt. Professor Oncology     2008-2011
    G.G.S. Medical college.,Faridkot
  • Senior Registrar radiation Oncologist     2005-2008
    A.I.I.M.S.,New Delhi.

RESEARCH & PUBLICATION

  • Thesis Presentation “ Comparative role of various chemotherapeutic agents in advanced carcinoma breast as adjuvant to radiotherapy”
  • hippocampal Avoidance whole brain rt Vs conventional whole brain rt.a comparison”.ESTRO 2014 Vienna,,Austria.
  • “Cisplatin based new regimens-A study in advanced /recurrent carcinoma breast.”25th national annual conference of AROI.
  • “Role of Gemcitabine as a radiation sensitizer in management of advanced head and neck cancer.”AROI UPCon 2004.
  • “Comparative study of various dose models using extended Linear-Quadratic model with proliferation effect.” Journal of medical Physics 2004.
  • “Accelerated fractionation in advanced carcinoma oral cavity, oropharynx, and hypopharynx-A feasibility study.” RGCON 2006, 5th international conference.
  • “Acute and Late Sequelae in post irradiated Cancer Cervix Patients”Journal of Obs and Gynae, AIIMS, New Delhi.

What Our Patients Say